A Provisional Biopharmaceutical Classification of the Top 200 Oral Drug Products in the United States, Great Britain, Spain, and Japan
Top Cited Papers
- 3 October 2006
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 3 (6), 631-643
- https://doi.org/10.1021/mp0600182
Abstract
Orally administered, immediate-release (IR) drug products in the top 200 drug product lists from the United States (US), Great Britain (GB), Spain (ES), and Japan (JP) were provisionally classified based on the Biopharmaceutics Classification System (BCS). The provisional classification is based on the aqueous solubility of the drugs reported in readily available reference literature and a correlation of human intestinal membrane permeability for a set of 29 reference drugs with their calculated partition coefficients. Oral IR drug products constituted more that 50% of the top 200 drug products on all four lists, and ranged from 102 to 113 in number. Drugs with dose numbers less than or equal to unity are defined as high-solubility drugs. More than 50% of the oral IR drug products on each list were determined to be high-solubility drugs (55−59%). The provisional classification of permeability is based on correlations of the human intestinal permeabilities of 29 reference drugs with the calculated Log P or CLogP lipophilicity values for the uncharged chemical form. The Log P and CLogP estimates were linearly correlated (r2 = 0.79) for 187 drugs. Metoprolol was chosen as the reference compound for permeability and Log P or CLogP. A total of 62−69.0% and 56−60% of the drugs on the four lists exhibited CLogP and Log P estimates, respectively, greater than or equal to the corresponding metoprolol value and are provisionally classified as high-permeability drugs. We have compared the BCS classification in this study with the recently proposed BDDCS classification based on fraction dose metabolism. Although the two approaches are based on different in vivo processes, fraction dose metabolized and fraction dose absorbed are highly correlated and, while depending on the choice of reference drug for permeability classification, e.g., metoprolol vs cimetidine or atenolol, show excellent agreement in drug classification. In summary, more than 55% of the drug products were classified as high-solubility (Class 1 and Class 3) drugs in the four lists, suggesting that in vivo bioequivalence (BE) may be assured with a less expensive and more easily implemented in vitro dissolution test. Keywords: BCS; solubility; dose number; permeability; partition coefficient; WHO essential drugs; top-selling US, European, Japanese drugs; BDDCSKeywords
This publication has 25 references indexed in Scilit:
- Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: Chloroquine phosphate, chloroquine sulfate, and chloroquine hydrochloride**This study reflects the scientific opinion of the authors and not the policies of regulating agencies.Journal of Pharmaceutical Sciences, 2005
- Comparison of the octanol/water partition coefficients calculated by ClogP®, ACDlogP and KowWin® to experimentally determined valuesInternational Journal of Pharmaceutics, 2005
- Summary workshop report: Biopharmaceutics classification system—implementation challenges and extension opportunitiesJournal of Pharmaceutical Sciences, 2004
- Functional properties of multispecific amino acid transporters and their implications to transporter-mediated toxicity.The Journal of Toxicological Sciences, 2003
- Active transport of the angiotensin‐II antagonist losartan and its main metabolite EXP 3174 across MDCK‐MDR1 and Caco‐2 cell monolayersBritish Journal of Pharmacology, 2000
- Correlation of Human Jejunal Permeability (in Vivo) of Drugs with Experimentally and Theoretically Derived Parameters. A Multivariate Data Analysis ApproachJournal of Medicinal Chemistry, 1998
- Differential Recognition of β-Lactam Antibiotics by Intestinal and Renal Peptide Transporters, PEPT 1 and PEPT 2Journal of Biological Chemistry, 1995
- Pharmacokinetics of Digoxin and Main Metabolites/Derivatives in Healthy HumansTherapeutic Drug Monitoring, 1991
- Atomic physicochemical parameters for three-dimensional-structure-directed quantitative structure-activity relationships. 2. Modeling dispersive and hydrophobic interactionsJournal of Chemical Information and Computer Sciences, 1987
- Pharmacokinetics of Cimetidine after Single Doses and during Continuous TreatmentClinical Pharmacokinetics, 1981